These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22489591)

  • 1. Psychosis induced by the interaction between disulfiram and methylphenidate may be dose dependent.
    Grau-López L; Roncero C; Navarro MC; Casas M
    Subst Abus; 2012; 33(2):186-8. PubMed ID: 22489591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of disulfiram-methylphenidate interaction: implications for treatment.
    Caci H; Baylé F
    Am J Psychiatry; 2007 Nov; 164(11):1759. PubMed ID: 17974945
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychosis in a cocaine-dependent patient with ADHD during treatment with methylphenidate.
    Delavenne H; Duarte Garcia F; Lacoste J; Cortese S; Charles-Nicolas A; Ballon N
    Gen Hosp Psychiatry; 2013; 35(4):451.e7-9. PubMed ID: 22739113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Jafarinia M; Mohammadi MR; Modabbernia A; Ashrafi M; Khajavi D; Tabrizi M; Yadegari N; Akhondzadeh S
    Hum Psychopharmacol; 2012 Jul; 27(4):411-8. PubMed ID: 22806822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial.
    Mohammadi MR; Kazemi MR; Zia E; Rezazadeh SA; Tabrizi M; Akhondzadeh S
    Hum Psychopharmacol; 2010 Nov; 25(7-8):560-5. PubMed ID: 21312290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.
    Bron TI; Bijlenga D; Kasander MV; Spuijbroek AT; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):542-54. PubMed ID: 22809706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
    Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
    Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief psychosis induced by methylphenidate in a child with attention deficit disorder: a case report and literature review.
    Martínez-Aguayo JC; Arancibia M; Meza-Concha N; Bustamante C; Pérez-Bracchiglione J; Madrid E
    Medwave; 2017 Jun; 17(5):e6980. PubMed ID: 28665917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Disulfiram-Induced Psychosis in a Previously Asymptomatic Patient Maintained on Mixed Amphetamine Salts: A Review of the Literature and Possible Pathophysiological Explanations.
    Spiegel DR; McCroskey A; Puaa K; Meeker G; Hartman L; Hudson J; Hung YC
    Clin Neuropharmacol; 2016; 39(5):272-5. PubMed ID: 27466724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced psychosis after intake of a modified--release formulation of methylphenidate].
    Greiner C; Enss E; Haen E
    Psychiatr Prax; 2009 Mar; 36(2):89-91. PubMed ID: 18504693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 13. ADHD and addiction.
    Robbins TW
    Nat Med; 2002 Jan; 8(1):24-5. PubMed ID: 11786901
    [No Abstract]   [Full Text] [Related]  

  • 14. [Infantile psychosis secondary to methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of osmotic-release oral system methylphenidate on learning skills in adolescents with attention-deficit/hyperactivity disorder: an open-label study.
    Na KS; Lee SI; Hong SD; Kim JH; Shim SH; Choi J; Yang J; Lee MS; Joung YS; Kim EJ; Park JH
    Int Clin Psychopharmacol; 2013 Jul; 28(4):184-92. PubMed ID: 23587983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder: monitoring in biological matrices].
    Papaseit E; García-Algar O; Simó S; Pichini S; Farré M
    An Pediatr (Barc); 2013 Feb; 78(2):123.e1-10. PubMed ID: 23063334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug dependence and methylphenidate].
    Sora I; Ikari M; Ikeda K
    Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
    [No Abstract]   [Full Text] [Related]  

  • 18. Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.
    Cho SC; Kim BN; Cummins TD; Kim JW; Bellgrove MA
    J Psychopharmacol; 2012 Mar; 26(3):380-9. PubMed ID: 21628343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
    Blom JD; Kooij JJ
    Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis during disulfiram therapy for alcoholism.
    Murthy KK
    J Indian Med Assoc; 1997 Mar; 95(3):80-1. PubMed ID: 9212576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.